Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for American Well Corporation (Amwell) (NYSE: AMWL) brings together the company’s official regulatory disclosures, as filed with the U.S. Securities and Exchange Commission. These documents provide detailed information on Amwell’s financial reporting, material agreements and other significant corporate events related to its digital care and technology-enabled healthcare platform.
Among the key filings are Form 8‑K current reports, which Amwell uses to announce material events. Recent 8‑K filings include disclosures of quarterly financial results, with earnings reports furnished as exhibits and details on investor conference calls and webcasts. Other 8‑K filings describe material definitive agreements, such as amendments and statements of work with Elevance Health under which Amwell operates the LiveHealth Online white‑label digital care platform and receives annual subscription fees and related service fees.
Filings also outline amendments to provider agreements involving Online Care Group, P.C., Amwell’s clinical partner, which maintains a 50‑state network of clinical professionals delivering digital care consultations via the LiveHealth Online platform. These documents specify contract terms, renewal provisions and termination rights, offering insight into how Amwell structures long‑term partnerships that support its technology-enabled care services.
On Stock Titan, investors can use AI-powered tools to read and interpret Amwell’s SEC filings more efficiently. AI summaries highlight the main points of lengthy documents, explain the implications of material agreements and clarify the context of earnings-related disclosures. Real-time updates from EDGAR ensure that new 8‑K filings and other reports appear promptly, while structured access to exhibits helps users locate information on subscription arrangements, provider networks and other aspects of Amwell’s business.
For anyone analyzing AMWL, this page serves as a focused entry point into Amwell’s regulatory history, combining raw SEC documents with AI-generated explanations that make complex legal and financial language easier to understand.
HIRSCHHORN MARK reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp reported that its Chief Financial Officer, Mark Hirschhorn, received an equity award tied to 50,413 shares of Class A common stock on March 4, 2026. The award was granted at no cash cost per share.
According to the footnote, this represents a grant of restricted stock units that will vest in equal quarterly installments over a two-year period, starting on the first calendar day of the month after three months from the grant date. Following this award, Hirschhorn directly holds 253,999 shares of Class A common stock.
American Well Corp executive Phyllis Gotlib reported an equity award of company stock. She acquired 50,413 shares of Class A Common Stock as a grant of restricted stock units with a stated price of $0.00 per share. Following this award, she directly holds 166,710 shares.
The RSUs will vest in equal quarterly installments over a two-year period, beginning on the first calendar day of the month after three months from the grant date and continuing until fully vested after 24 months. In addition, 114,250 shares are reported as indirectly owned through her husband.
American Well Corp (AMWL) reported that Chief Product & Tech. Officer Dmitry Zamansky acquired 50,413 shares of Class A Common Stock through a grant or award on March 4, 2026 at a price of $0.00 per share. After this transaction, his directly owned stake in Class A Common Stock totaled 246,655 shares.
According to the footnote, this award represents restricted stock units (RSUs) that vest in equal quarterly installments over two years. Vesting begins on the first calendar day of the month after three months from the grant date and continues quarterly until the first calendar day of the month following the 24‑month anniversary.
McNeice Paul Francis reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp Chief Accounting Officer Paul Francis McNeice reported an equity award of 8,066 shares of Class A common stock on a grant basis at $0.0000 per share. After this grant, he directly holds 10,999 shares of Class A common stock.
The award represents restricted stock units that will vest in equal quarterly installments over two years. Vesting begins on the first calendar day of the month after three months from the grant date and continues until the month following the 24‑month anniversary.
American Well Corp Chief Product & Tech. Officer Dmitry Zamansky sold 2,472 shares of Class A common stock in an open-market transaction at $5.45 per share. The trade was executed under a Rule 10b5-1 trading plan adopted on December 1, 2025, leaving him with 196,242 directly owned shares.
American Well Corp Chief Financial Officer Mark Hirschhorn reported an open-market sale of 10,796 shares of Class A common stock at $5.24 per share. According to the filing, the sale was an automatic “sell to cover” transaction to pay taxes on restricted stock units that vested on March 1, 2026, and not a discretionary trade. After this tax-related sale, he directly holds 203,586 shares.
American Well Corp President, International Phyllis Gotlib sold 3,573 shares of Class A Common Stock in an open-market transaction. The sale took place on March 2, 2026 at a price of $5.24 per share, leaving her with 116,297 shares held directly.
According to the disclosure, this was an automatic “sell to cover” transaction to satisfy tax liabilities from restricted stock units that vested and settled on March 1, 2026. The filing states that the sale did not represent a discretionary trade by the reporting person.
American Well Corp's Chief Accounting Officer, Paul Francis McNeice, reported an open-market sale of 130 shares of Class A common stock at
American Well Corporation submitted a Form 144 notice reporting a proposed sale of 15,890 shares of Class A common stock tied to the vesting of a restricted stock unit grant on
American Well Corporation filed a Form 144 reporting proposed sales of Class A Common Stock.
The notice lists securities-related activity tied to restricted stock unit vesting and prior transfers, including a RSU vesting of 6,786 shares on 03/01/2026 and examples of transfers: Phyllis Gotlib – 3,707 shares on 01/02/2026 and 3,574 shares on 12/01/2025.